ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4,201 | 65.16095 | 1 |
male
| 0 | 21 | 214 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 8 | null | 0 | 27,118.438 | 18,046.5625 | null | 20.333328 |
white
| 30.199219 | 44 | 0.710938 | 0.550903 | 1 | 1 | 0 |
no
| 0.8 | 0.7 |
dnr after sadm
| 4 | 63 | 7.299805 | 100 | 11 | 36.39844 | 300 | 3 | null | 2.799805 | 130 | 7.439453 | null | null | null | 4 | null | null | 3.183199 |
4,202 | 37.50598 | 1 |
male
| 1 | 9 | 9 |
Coma
|
Coma
| 1 | 12 |
$11-$25k
| 61 | 69,511.312 | 44,734.5625 | null | 29.5 |
white
| 20 | 17 | 0.653931 | 0.593994 | 23 | 0 | 0 |
no
| null | null |
dnr after sadm
| 2 | 113 | 4.5 | 44 | 6 | 36.89844 | 547.5 | null | null | 0.899902 | 154 | 7.429688 | null | null | null | null | null |
<2 mo. follow-up
| 2.008789 |
4,203 | 71.56195 | 1 |
female
| 1 | 43 | 43 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 |
under $11k
| 26 | 171,998.75 | 108,769.625 | null | 38.75 |
white
| 25.5 | 42 | 0.566895 | 0.455994 | 23 | 1 | 0 |
no
| 0.5 | 0.4 |
dnr after sadm
| 27 | 123 | 6.799805 | 120 | 7 | 38.69531 | 450 | 1.799805 | 6.199219 | 0.699951 | 150 | 7.5 | null | null | null | null | null |
<2 mo. follow-up
| 2.337891 |
4,204 | 71.95599 | 0 |
female
| 0 | 10 | 1,348 |
CHF
|
COPD/CHF/Cirrhosis
| 0 | null | null | 0 | 15,265.047 | 10,070.7109 | null | 20 |
black
| 26.898438 | 29 | 0.737915 | 0.587891 | 1 | 0 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 10 | 75 | 10.398438 | 106 | 26 | 36.79688 | 234.78125 | 2.399902 | 0.799927 | 0.699951 | 141 | 7.389648 | null | null | null | null | null | null | 2.376953 |
4,205 | 63.52399 | 0 |
male
| 0 | 7 | 1,348 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 5 |
under $11k
| 0 | 8,887.242 | 6,031.0938 | null | 11.5 |
white
| 22.898438 | 23 | 0.826904 | 0.768921 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 7 | 67 | 17.597656 | 126 | 20 | 35.79688 | 312 | null | 0.699951 | 1 | 139 | 7.459961 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,206 | 45.24597 | 1 |
male
| 1 | 3 | 3 |
Coma
|
Coma
| 0 | 12 |
$11-$25k
| 89 | 29,102.234 | 18,106.1875 | null | 48 |
white
| 81.09375 | 80 | 0 | 0 | 3 | 0 | 0 |
no
| null | null |
dnr after sadm
| 2 | 0 | 15.099609 | 0 | 0 | 39.19531 | 195 | null | null | 2 | 181 | 7.40918 | null | null | null | null | null |
<2 mo. follow-up
| 1.310547 |
4,207 | 78.86896 | 1 |
male
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 26 | 60,337.531 | 35,466.3125 | null | 22 |
white
| 27.5 | 41 | 0.496948 | 0.379944 | 8 | 0 | 0 |
no
| null | null |
dnr after sadm
| 4 | 105 | 16 | 110 | 32 | 38.5 | 197.125 | null | null | 2.699707 | 136 | 7.429688 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,208 | 42.215 | 0 |
female
| 0 | 110 | 1,345 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 0 | 166,448.625 | 111,714.688 | null | 19.75 |
black
| 31.796875 | 49 | 0.717896 | 0.631958 | 7 | 0 | 0 |
no
| null | null |
no dnr
| 110 | 160 | 29.898438 | 130 | 42 | 38.29688 | 170 | 2.5 | 4.399414 | 0.699951 | 133 | 7.399414 | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.564941 |
4,209 | 33.66699 | 0 |
male
| 0 | 11 | 1,345 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 9 |
under $11k
| 0 | 29,377.688 | 20,656.7031 | null | 25 |
white
| 20.597656 | 32 | 0.893921 | 0.822998 | 1 | 0 | 0 |
no
| 0.6 | 0.5 |
no dnr
| 11 | 108 | 5.299805 | 74 | 26 | 38.5 | 300 | 2.299805 | 7.399414 | 0.699951 | 136 | 7.419922 | null | null | null | 2 | null | null | 1.839 |
4,210 | 81.53296 | 1 |
female
| 0 | 11 | 26 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 14 |
$11-$25k
| 26 | 25,805.188 | 17,326.8438 | null | 24 |
white
| 20.5 | 33 | 0.724976 | 0.640991 | 1 | 0 | 1 |
no
| 0.5 | 0.3 |
dnr after sadm
| 3 | 107 | 10.298828 | 126 | 30 | 38.59375 | 240 | 2.799805 | 0.199982 | 0.799927 | 143 | 7.389648 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
4,211 | 43.88998 | 0 |
male
| 0 | 14 | 1,345 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 20 |
$11-$25k
| 0 | 48,116.688 | 31,653.0781 | null | 21.666656 |
white
| 30.597656 | 37 | 0.75 | 0.670898 | 4 | 0 | 0 |
no
| 1 | 1 |
no dnr
| 14 | 100 | 16.699219 | 114 | 25 | 36.59375 | 147.5 | 3 | 0.5 | 1.699951 | 153 | 7.509766 | null | null | null | null | 1 |
SIP>=30
| 1 |
4,212 | 69.07599 | 1 |
female
| 0 | 11 | 269 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 8 |
under $11k
| 0 | 12,173.898 | 8,183.8711 | null | 17.5 |
white
| 24.597656 | 25 | 0.78894 | 0.661987 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 11 | 49 | 8.898438 | 66 | 24 | 35.59375 | 385.6875 | null | 0.5 | 0.699951 | 138 | 7.40918 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
4,213 | 54.56799 | 1 |
male
| 1 | 18 | 18 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 0 | null | 0 | 89,779.188 | 57,363.9688 | null | 45.666657 |
black
| 40.296875 | 60 | 0.516968 | 0.40094 | 1 | 0 | 0 |
no
| 0.5 | 0.4 |
dnr after sadm
| 17 | 56 | 4.099609 | 136 | 14 | 38.09375 | 128 | 2.599609 | 4.299805 | 4.5 | 141 | 7.489258 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,214 | 31.034 | 1 |
female
| 0 | 14 | 47 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 8 |
$11-$25k
| 55 | 62,115.281 | 39,471.7188 | null | 29.666656 |
white
| 23.199219 | 44 | 0.424988 | 0.305969 | 17 | 0 | 0 |
yes
| 0.5 | 0.1 |
dnr after sadm
| 4 | 110 | 11.599609 | 124 | 32 | 39 | 300 | 1.899902 | 0.399963 | 1.5 | 146 | 7.399414 | null | null | null | null | 5 |
<2 mo. follow-up
| 5 |
4,215 | 78.78998 | 1 |
female
| 1 | 10 | 10 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 15 |
$25-$50k
| 9 | 53,350.75 | 35,540.5 | null | 31 |
white
| 39.695313 | 80 | 0.21698 | 0.119995 | 11 | 0 | 0 |
no
| 0.4 | 0.5 |
no dnr
| 10 | 115 | 0.799927 | 136 | 32 | 34.79688 | 480 | 2.099609 | 0.699951 | 3.599609 | 138 | 7.479492 | null | null | null | null | 5 |
<2 mo. follow-up
| 5 |
4,216 | 68.20294 | 1 |
male
| 0 | 35 | 37 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$25-$50k
| 0 | 141,644.125 | 89,196.3125 | null | 31 |
white
| 31.796875 | 53 | 0.565918 | 0.453979 | 10 | 0 | 0 |
no
| null | null |
no dnr
| 35 | 53 | 41.5 | 90 | 15 | 37.59375 | 260 | 2.799805 | 1.099854 | 3.299805 | 127 | 7.509766 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,217 | 21.506 | 0 |
female
| 0 | 25 | 1,341 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 0 | 78,420.438 | 50,620.8125 | null | 36.5 |
black
| 27 | 33 | 0.879883 | 0.837891 | 2 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 25 | 63 | 25.699219 | 120 | 28 | 38.59375 | 147.5 | 2.799805 | 0.799927 | 0.699951 | 137 | 7.419922 | null | null | null | null | 0 | null | 0 |
4,218 | 52.05197 | 0 |
male
| 0 | 26 | 1,339 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 15 |
$25-$50k
| 26 | null | null | null | 29.25 |
white
| 26.199219 | 36 | 0.799927 | 0.677979 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 26 | 150 | 9.298828 | 136 | 24 | 36.09375 | 188 | 3 | 0.199982 | 0.799927 | 143 | 7.389648 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
4,219 | 36.00497 | 1 |
female
| 0 | 15 | 109 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 17 | null | 0 | 34,299.781 | 22,116.7969 | null | 22 |
white
| 21.097656 | 34 | 0.882935 | 0.804932 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 15 | 63 | 9.398438 | 72 | 10 | 36.39844 | 213.3125 | 2.399902 | 5.099609 | 0.799927 | 133 | 7.439453 | null | null | null | null | 6 | null | 6 |
4,220 | 71.10199 | 1 |
male
| 0 | 12 | 259 |
Lung Cancer
|
Cancer
| 1 | 8 |
$25-$50k
| 0 | 16,560.844 | 10,550.1875 | null | 10 |
white
| 25.097656 | 15 | 0.493958 | 0.173981 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 12 | 78 | 9.5 | 98 | 20 | 36.89844 | 347.5625 | 2.799805 | 0.5 | 0.599976 | 141 | 7.439453 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,221 | 77.03198 | 1 |
female
| 1 | 4 | 4 |
Coma
|
Coma
| 0 | 11 |
under $11k
| 61 | 22,531.438 | 13,481.4766 | null | 33 |
white
| 22.199219 | 23 | 0.334961 | 0.261963 | 1 | 0 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 3 | 108 | 11.5 | 106 | 32 | 36.09375 | 414.25 | null | null | 0.899902 | 134 | 7.609375 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,222 | 55.42499 | 1 |
male
| 0 | 25 | 39 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1 | 19 | null | 26 | 74,816.188 | 47,502.25 | null | 24.75 |
white
| 27.199219 | 37 | 0.585938 | 0.393982 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 25 | 61 | 10.699219 | 120 | 8 | 35.69531 | 162.5 | 1.5 | 1.799805 | 1.299805 | 135 | 7.419922 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,223 | 53.84299 | 1 |
male
| 0 | 28 | 244 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 7 |
under $11k
| 0 | 68,604.688 | 43,377.3125 | null | 27.5 |
white
| 21.597656 | 22 | 0.875977 | 0.792969 | 1 | 1 | 0 |
no
| 0.5 | 0.45 |
no dnr
| 28 | 60 | 9.898438 | 126 | 24 | 38.5 | 273.3125 | 3.099609 | 0.399963 | 0.899902 | 133 | 7.389648 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
4,224 | 44.89499 | 0 |
male
| 0 | 9 | 1,335 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 11 | null | 0 | 35,564.938 | 22,103.875 | null | 24.5 |
black
| 30.699219 | 48 | 0.778931 | 0.707886 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 9 | 72 | 11.298828 | 58 | 28 | 38.69531 | 102.5 | 3 | 0.199982 | 3 | 141 | 7.399414 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,225 | 72.34198 | 1 |
male
| 0 | 4 | 125 |
Lung Cancer
|
Cancer
| 2 | 8 | null | 0 | 4,382.75 | 2,688.4356 | null | 9 |
white
| 18.796875 | 18 | 0.651978 | 0.345947 | 1 | 1 | 0 |
metastatic
| 0.9 | 0.7 |
no dnr
| 4 | 109 | 11.898438 | 76 | 16 | 36.79688 | null | 3.099609 | 0.299988 | 0.899902 | 140 | null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.300781 |
4,226 | 58.491 | 1 |
male
| 1 | 6 | 6 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 9 | 19,705.547 | 12,076.5703 | null | 51 |
black
| 35.296875 | 63 | 0.584961 | 0.475952 | 1 | 1 | 0 |
no
| null | null |
dnr after sadm
| 5 | 61 | 14.199219 | 134 | 44 | 37.69531 | 122 | 3 | 0.899902 | 2.699707 | 135 | 7.279297 | null | null | null | null | null |
<2 mo. follow-up
| 2.405762 |
4,227 | 61.91898 | 1 |
male
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 5 |
under $11k
| 37 | 53,453.531 | 32,532.9219 | null | 42.5 |
white
| 32.59375 | 48 | 0.440979 | 0.32196 | 4 | 0 | 0 |
no
| 0.5 | 0.4 |
dnr after sadm
| 6 | 59 | 3.5 | 106 | 10 | 36.29688 | 197.5 | 3.399902 | 1.899902 | 7 | 133 | 7.25 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,228 | 91.20898 | 1 |
male
| 0 | 28 | 63 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null |
$25-$50k
| 37 | 175,216.125 | 115,518 | null | 24.75 |
white
| 26.898438 | 49 | 0.335999 | 0.219971 | 24 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 28 | 74 | 11.898438 | 70 | 32 | 37.69531 | 222.84375 | 3.299805 | 11 | 1.5 | 154 | 7.429688 | null | null | null | null | null | null | 3.289063 |
4,229 | 64.97998 | 1 |
female
| 1 | 24 | 24 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
under $11k
| 37 | 80,000.812 | 53,980 | null | 38.666657 |
white
| 38.09375 | 60 | 0.31897 | 0.204987 | 1 | 1 | 0 |
no
| 0.3 | 0.2 |
dnr after sadm
| 23 | 115 | 19.699219 | 134 | 26 | 37.89844 | 115.54688 | 1.399902 | 1.699951 | 2.899902 | 129 | 7.399414 | null | null | null | null | null |
<2 mo. follow-up
| 2.566406 |
4,230 | 72.24097 | 1 |
male
| 0 | 24 | 60 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 0 | null | 0 | 143,222.5 | 87,619.625 | null | 46.333313 |
white
| 32.5 | 46 | 0.495972 | 0.377991 | 26 | 0 | 0 |
no
| 0.6 | 0.5 |
no dnr
| 24 | 121 | 4.399414 | 134 | 29 | 36.5 | 193.3125 | null | null | 2.699707 | 137 | 7.399414 | null | null | null | null | null | null | 2.198731 |
4,231 | 75.67395 | 1 |
female
| 1 | 23 | 23 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 14 |
$11-$25k
| 9 | 171,279.125 | 106,489.75 | null | 49 |
white
| 33.898438 | 61 | 0.40094 | 0.281982 | 14 | 1 | 0 |
no
| null | null |
dnr after sadm
| 23 | 60 | 22.5 | 136 | 9 | 35.89844 | 202.5 | 2.399902 | 3.099609 | 2 | 152 | 7.40918 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,232 | 25.56899 | 0 |
female
| 0 | 38 | 1,331 |
Coma
|
Coma
| 0 | 17 |
$11-$25k
| 44 | 85,945.312 | 57,810.7188 | null | 22.25 |
white
| 24.796875 | 19 | 0.781982 | 0.73999 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 38 | 73 | 6.899414 | 40 | 8 | 35 | 519 | 3.799805 | 1.5 | 0.599976 | 142 | 7.519531 | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,233 | 58.81198 | 1 |
male
| 1 | 11 | 11 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 9 | 54,651.594 | 33,309.8125 | null | 42.5 |
black
| 33.09375 | 53 | 0.54895 | 0.434998 | 10 | 1 | 0 |
no
| 0.4 | 0.1 |
dnr after sadm
| 11 | 76 | 12.599609 | 130 | 30 | 36.19531 | 187.5 | 2.299805 | null | 3.199707 | 134 | 7.449219 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,234 | 66.92395 | 1 |
male
| 0 | 7 | 183 |
Colon Cancer
|
Cancer
| 1 | 15 |
$11-$25k
| 0 | 7,351.648 | 4,601.1953 | null | 10.5 |
white
| 14 | 15 | 0.850952 | 0.670898 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 7 | 107 | 5.399414 | 64 | 20 | 37.09375 | null | null | 0.799927 | 1 | 141 | null | null | null | null | null | 0 | null | 0 |
4,235 | 78.78699 | 1 |
male
| 1 | 74 | 74 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 41 | null | null | null | 37.5 |
white
| 30.199219 | 59 | 0.323975 | 0.209991 | 12 | 0 | 0 |
no
| 0.5 | 0.4 |
no dnr
| 74 | 83 | 25.097656 | 120 | 4 | 38.39844 | 157.5 | 2.399902 | 1.199951 | 1.699951 | 137 | 7.30957 | null | null | null | null | 0 | null | 0 |
4,236 | 27.661 | 0 |
male
| 0 | 7 | 1,327 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 0 | 22,497.688 | 14,607.8906 | null | 12 |
black
| 19 | 14 | 0.92395 | 0.896973 | 3 | 0 | 0 |
no
| 1 | 1 |
no dnr
| 7 | 110 | 14.398438 | 100 | 22 | 36.29688 | 260 | 2.5 | null | 0.899902 | 138 | 7.449219 | null | null | null | null | null | null | 2.190918 |
4,237 | 58.823 | 1 |
male
| 1 | 23 | 23 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 0 | 109,539.875 | 70,529.375 | null | 44 |
white
| 25.5 | 40 | 0.746948 | 0.666992 | 13 | 1 | 0 |
no
| 0.6 | 0.5 |
dnr after sadm
| 16 | 117 | 12.798828 | 110 | 13 | 36.39844 | 180 | 1.199951 | 0.799927 | 0.899902 | 133 | 7.419922 | null | null | null | null | 4 |
<2 mo. follow-up
| 4 |
4,238 | 73.37994 | 1 |
female
| 0 | 45 | 676 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 41 | null | null | null | 16.5 |
black
| 21.699219 | 33 | 0.592896 | 0.484985 | 17 | 0 | 0 |
no
| 0.8 | 0.85 |
no dnr
| 45 | 124 | 6.299805 | 116 | 28 | 37.79688 | 204 | null | null | 0.899902 | 144 | 7.439453 | null | null | null | null | 0 | null | 0 |
4,239 | 54.431 | 1 |
female
| 0 | 4 | 261 |
Colon Cancer
|
Cancer
| 1 | null | null | 0 | 2,386.049 | 1,735.0772 | null | 13 |
white
| 24.199219 | 12 | 0.723999 | 0.448975 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 4 | 76 | 5 | 104 | 20 | 39 | null | 2.799805 | null | 0.899902 | 137 | null | null | null | null | null | null | null | 1.887451 |
4,240 | 70.12195 | 1 |
female
| 1 | 24 | 24 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 37 | 92,355.25 | 54,605 | null | 53 |
black
| 27.5 | 32 | 0.543945 | 0.429993 | 3 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 22 | 56 | 14.199219 | 124 | 10 | 35.69531 | 237.125 | null | 0.099991 | 1.199951 | 154 | 7.529297 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,241 | 76.20496 | 1 |
male
| 1 | 11 | 11 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 41 | 38,628.625 | 24,617.3281 | null | 40.5 |
white
| 36.296875 | 90 | 0.075989 | 0.028 | 2 | 0 | 0 |
metastatic
| 0.1 | 0.001 |
dnr before sadm
| 0 | 59 | 0.099991 | 136 | 28 | 36.39844 | 250 | 1.899902 | 2.199707 | 2.099609 | 143 | 7.429688 | null | null | null | null | 3 |
<2 mo. follow-up
| 3 |
4,242 | 80.71198 | 0 |
female
| 0 | 34 | 1,324 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 61 | 61,520.188 | 41,577.7188 | null | 24.25 |
white
| 15.199219 | 13 | 0.666992 | 0.570923 | 4 | 0 | 0 |
no
| 0.25 | 0.1 |
no dnr
| 34 | 75 | 9.599609 | 66 | 9 | 37.5 | 225.6875 | 2.599609 | null | 0.699951 | 141 | 7.479492 | null | null | null | null | 3 |
adl>=4 (>=5 if sur)
| 3 |
4,243 | 47.918 | 1 |
male
| 0 | 5 | 37 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 10 |
under $11k
| 0 | 3,757 | 2,664.832 | null | 4 |
black
| 26.796875 | 48 | 0.75293 | 0.609985 | 1 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 5 | 118 | 15.599609 | 91 | 44 | 37.89844 | null | 2.399902 | 22 | 1.099854 | 136 | null | null | null | null | 0 | 0 |
<2 mo. follow-up
| 0 |
4,244 | 68.32599 | 1 |
male
| 0 | 7 | 57 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$11-$25k
| 0 | 20,914.094 | 14,036.7734 | null | 17.5 |
white
| 31.5 | 41 | 0.598999 | 0.409973 | 6 | 1 | 0 |
no
| 0.7 | 0.3 |
no dnr
| 7 | 46 | 12.199219 | 60 | 32 | 36.39844 | 338.0625 | null | null | 1 | 128 | 7.519531 | null | null | null | 1 | 0 |
<2 mo. follow-up
| 0 |
4,245 | 58.03699 | 1 |
male
| 1 | 16 | 16 |
Coma
|
Coma
| 1 | null | null | 100 | null | null | null | 24 |
white
| 23.296875 | 43 | 0.294983 | 0.223999 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 4 | 109 | 14.298828 | 130 | 28 | 39 | 270 | 1.799805 | 0.799927 | 1.699951 | 141 | 7.349609 | null | null | null | null | null |
<2 mo. follow-up
| 2.536133 |
4,246 | 54.63098 | 0 |
female
| 0 | 113 | 1,321 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 7 |
under $11k
| 0 | null | null | null | 38.75 |
white
| 24 | 27 | 0.784912 | 0.713989 | 16 | 0 | 0 |
no
| 0.4 | 0.4 |
no dnr
| 113 | 99 | 23.5 | 184 | 14 | 38.5 | 236.65625 | null | 0.799927 | 0.399963 | 135 | 7.449219 | null | null | null | null | 7 | null | 7 |
4,247 | 54.40399 | 0 |
female
| 0 | 31 | 1,320 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 41 | 77,659.062 | 52,406.4375 | null | 29.5 |
white
| 26.898438 | 50 | 0.672974 | 0.576904 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 31 | 69 | 5.799805 | 106 | 23 | 38.59375 | 113.84375 | 1.599854 | 0.899902 | 1.699951 | 142 | 7.55957 | null | null | null | null | null | null | 2.958008 |
4,248 | 70.43695 | 1 |
female
| 1 | 21 | 21 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 196,870.625 | 117,628.062 | null | 52 |
white
| 41.5 | 71 | 0.265991 | 0.159973 | 11 | 0 | 0 |
no
| null | null |
dnr after sadm
| 19 | 59 | 46.5 | 138 | 30 | 35.89844 | 272.5 | null | 5.199219 | 4.399414 | 127 | 7.359375 | null | null | null | null | null |
<2 mo. follow-up
| 2.1875 |
4,249 | 68.85095 | 1 |
male
| 0 | 16 | 220 |
Colon Cancer
|
Cancer
| 1 | null | null | 0 | 18,922.438 | 12,394.3828 | null | 16.666656 |
white
| 28.597656 | 50 | 0.580933 | 0.260986 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 16 | 133 | 13.699219 | 128 | 36 | 39.29688 | 276 | null | 6.099609 | 0.899902 | 134 | 7.489258 | null | null | null | null | null | null | 2.616211 |
4,250 | 54.08899 | 0 |
female
| 0 | 57 | 1,319 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 6 | null | 37 | 121,103.375 | 80,398.8125 | null | 25.5 |
black
| 21.398438 | 41 | 0.787964 | 0.718994 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 57 | 113 | 7.5 | 110 | 30 | 38.19531 | 368 | 2.799805 | 0.5 | 2.299805 | 144 | 7.469727 | null | null | null | null | 6 | null | 6 |
4,251 | 66.349 | 0 |
male
| 0 | 9 | 1,320 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 14 |
under $11k
| 0 | 13,372.742 | 9,138.5938 | null | 21.5 |
black
| 31.199219 | 36 | 0.684937 | 0.517944 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 9 | 127 | 14.699219 | 126 | 6 | 36.29688 | 182.84375 | 2.399902 | 0.5 | 1.399902 | 139 | 7.379883 | null | null | null | 1 | null |
SIP>=30
| 1.1669 |
4,252 | 60.89297 | 1 |
female
| 0 | 9 | 11 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 | null | 0 | 15,443.594 | 11,158.2109 | null | 14 |
white
| 19 | 16 | 0.882935 | 0.803955 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 9 | 103 | 13.898438 | 64 | 24 | 35.59375 | 252 | null | null | 1.199951 | 137 | 7.449219 | null | null | null | 2 | null |
<2 mo. follow-up
| 1.839 |
4,253 | 44.89798 | 1 |
male
| 1 | 5 | 5 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 12 |
under $11k
| 26 | 26,682.391 | 18,153.2812 | null | 42 |
white
| 39.09375 | 85 | 0.360962 | 0.168976 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 5 | 45 | 5.599609 | 174 | 36 | 38.19531 | 206 | 2.199707 | 11.699219 | 1.199951 | 132 | 7.55957 | null | null | null | null | 3 |
<2 mo. follow-up
| 3 |
4,254 | 69.20197 | 1 |
female
| 0 | 10 | 41 |
Lung Cancer
|
Cancer
| 1 | null | null | 0 | 6,285.047 | 4,821.9883 | null | 7 |
white
| 18.898438 | 9 | 0.657959 | 0.35498 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 10 | 93 | 9.298828 | 100 | 16 | 35.39844 | null | null | 0.5 | 0.899902 | 138 | null | null | null | null | null | null |
<2 mo. follow-up
| 2.80957 |
4,255 | 56.06299 | 0 |
female
| 0 | 5 | 1,317 |
CHF
|
COPD/CHF/Cirrhosis
| 5 | 12 | null | 0 | 8,491.492 | 5,716.0938 | null | 9 |
black
| 19.5 | 25 | 0.888916 | 0.813965 | 1 | 1 | 0 |
no
| 0.7 | 0.5 |
no dnr
| 5 | 73 | 9.699219 | 52 | 24 | 36.79688 | 376.1875 | null | null | 1.699951 | 136 | 7.419922 | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,256 | 75.14294 | 1 |
male
| 0 | 54 | 595 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 8 | null | 0 | 218,304.75 | 141,797.875 | null | 37.25 |
white
| 32.796875 | 57 | 0.339966 | 0.223999 | 17 | 0 | 0 |
yes
| null | null |
no dnr
| 54 | 133 | 0.299988 | 134 | 24 | 39 | 231.40625 | 2.399902 | 4.399414 | 1 | 152 | 7.429688 | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,257 | 77.42596 | 1 |
male
| 0 | 21 | 697 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 12 |
$11-$25k
| 0 | 42,596.344 | 28,186.9375 | null | 26.333328 |
white
| 33.796875 | 66 | 0.545898 | 0.432983 | 1 | 1 | 0 |
no
| 0.75 | 0.6 |
no dnr
| 21 | 63 | 15.798828 | 60 | 0 | 34.89844 | 343.3125 | 2.5 | null | 5.5 | 131 | 7.5 | null | null | null | null | 1 |
no(M2 and SIP pres)
| 1 |
4,258 | 64.51196 | 1 |
female
| 0 | 6 | 1,292 |
Colon Cancer
|
Cancer
| 1 | 15 |
$11-$25k
| 0 | 8,172.75 | 4,955.9102 | null | 16 |
white
| 15.898438 | 13 | 0.831909 | 0.633911 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 6 | 104 | 4.5 | 76 | 20 | 36.19531 | null | 3.399902 | 0.399963 | 0.799927 | 142 | null | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,259 | 57.57199 | 1 |
male
| 0 | 6 | 284 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 16 | null | 0 | 3,218.248 | 2,497.7969 | null | 12 |
hispanic
| 21.699219 | 28 | 0.86499 | 0.776978 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 6 | 110 | 8.099609 | 96 | 24 | 36.79688 | null | null | null | 3 | 144 | null | null | null | null | 1 | null | null | 1.1669 |
4,260 | 82.52698 | 1 |
male
| 1 | 7 | 7 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 5 |
under $11k
| 26 | 27,246.438 | 16,079.7734 | null | 37.5 |
black
| 53.796875 | 68 | 0.007 | 0 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 7 | 39 | 15.898438 | 134 | 20 | 36.69531 | 108.75 | 2.799805 | 0.399963 | 3.799805 | 132 | 7.319336 | null | null | null | null | 6 |
<2 mo. follow-up
| 6 |
4,261 | 64.961 | 1 |
female
| 0 | 42 | 564 |
MOSF w/Malig
|
ARF/MOSF
| 0 | 11 |
under $11k
| 37 | null | null | null | 14.5 |
black
| 22 | 43 | 0.55188 | 0.438965 | 3 | 0 | 0 |
yes
| 0.75 | 0.5 |
no dnr
| 42 | 137 | null | 106 | 30 | 38.5 | 350 | 2 | null | 2 | 132 | 7.469727 | null | null | null | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
4,262 | 90.71594 | 1 |
female
| 1 | 5 | 5 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 18 | null | 9 | 21,404.297 | 13,206.875 | null | 26 |
black
| 35.695313 | 54 | 0.306946 | 0.19397 | 3 | 0 | 0 |
no
| 0.25 | 0.2 |
dnr after sadm
| 5 | 108 | 12 | 100 | 36 | 35.19531 | 91.82812 | null | null | 1.899902 | 135 | 7.439453 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,263 | 69.21594 | 1 |
female
| 0 | 34 | 55 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 9 |
under $11k
| 0 | 86,351.562 | 55,435.9688 | null | 40 |
white
| 31.5 | 70 | 0.481995 | 0.363953 | 2 | 1 | 0 |
yes
| null | null |
no dnr
| 34 | 67 | 1.099854 | 170 | 32 | 35.79688 | 336.625 | 1.799805 | 0.599976 | 1.299805 | 147 | 7.299805 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
4,264 | 56.37198 | 1 |
male
| 1 | 13 | 13 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 17 | null | 0 | 42,452.438 | 27,247.7812 | null | 41.5 |
white
| 29.898438 | 59 | 0.668945 | 0.572998 | 2 | 0 | 0 |
yes
| null | null |
dnr after sadm
| 6 | 56 | 16.699219 | 140 | 12 | 39.89844 | 240 | 1.799805 | 3.199707 | 1.899902 | 143 | 7.359375 | null | null | null | null | null |
<2 mo. follow-up
| 2.12207 |
4,265 | 44.67398 | 1 |
female
| 0 | 5 | 134 |
Colon Cancer
|
Cancer
| 3 | 12 |
$11-$25k
| 0 | 2,538.799 | 1,843.1514 | null | 9 |
white
| 15.398438 | 14 | 0.86792 | 0.702881 | 1 | 1 | 0 |
metastatic
| null | null |
no dnr
| 5 | 73 | 4.799805 | 80 | 20 | 36.59375 | null | null | 0.5 | 0.599976 | 136 | null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.945557 |
4,266 | 26.752 | 0 |
male
| 0 | 14 | 1,310 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 10 | null | 0 | 35,316.125 | 23,421.3906 | null | 23 |
black
| 36.398438 | 46 | 0.756958 | 0.679932 | 1 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 14 | 51 | 21.699219 | 130 | 12 | 39.39844 | 108 | 2.199707 | 1.699951 | 1 | 137 | 7.349609 | null | null | null | null | 0 | null | 0 |
4,267 | 23.26399 | 0 |
male
| 0 | 22 | 1,309 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 11 | null | 9 | 93,008.875 | 58,490.0625 | null | 36.666657 |
black
| 25.5 | 34 | 0.86499 | 0.817993 | 4 | 0 | 0 |
no
| null | null |
no dnr
| 22 | 110 | 20.199219 | 110 | 38 | 38.69531 | 150 | 2.099609 | 0.899902 | 0.899902 | 143 | 7.449219 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
4,268 | 88.172 | 1 |
male
| 1 | 7 | 7 |
Coma
|
Coma
| 1 | null | null | 55 | 17,919.734 | 12,661.3359 | null | 15 |
white
| 17.898438 | 17 | 0.378967 | 0.304993 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 3 | 89 | 14.699219 | 54 | 14 | 37.09375 | 433.3125 | null | null | 1.099854 | 135 | 7.55957 | null | null | null | null | 4 |
<2 mo. follow-up
| 4 |
4,269 | 49.711 | 0 |
female
| 0 | 14 | 1,309 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 8 | null | 0 | 49,613.438 | 31,112.6875 | null | 23 |
white
| 27.199219 | 29 | 0.751953 | 0.67395 | 15 | 0 | 0 |
no
| 0.9 | 0.88 |
no dnr
| 14 | 82 | 8.898438 | 112 | 42 | 37.59375 | 180 | null | null | 0.5 | 131 | 7.5 | null | null | null | null | 2 |
no(M2 and SIP pres)
| 2 |
4,270 | 66.02295 | 1 |
female
| 1 | 11 | 11 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 10 |
under $11k
| 0 | 68,266.188 | 41,666.3125 | null | 50 |
white
| 25.898438 | 39 | 0.747925 | 0.668945 | 3 | 0 | 0 |
no
| 0.4 | 0.35 |
dnr after sadm
| 10 | 61 | 8 | 120 | 40 | 39.19531 | 147.25 | null | null | 0.799927 | 135 | 7.449219 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
4,271 | 73.86694 | 1 |
female
| 0 | 38 | 145 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 11 |
under $11k
| 44 | 139,384.25 | 91,699.9375 | null | 24.5 |
white
| 17.898438 | 16 | 0.672974 | 0.577881 | 13 | 0 | 0 |
no
| null | null |
dnr after sadm
| 21 | 63 | 9.099609 | 100 | 11 | 37.39844 | 336 | 3 | null | 0.5 | 140 | 7.479492 | null | null | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,272 | 76.97998 | 1 |
male
| 1 | 16 | 16 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | null | null | 0 | 58,267.438 | 38,300.0938 | null | 36.333313 |
white
| 39.296875 | 69 | 0.302979 | 0.190979 | 1 | 0 | 0 |
yes
| 0.6 | 0.55 |
dnr after sadm
| 11 | 45 | 4.299805 | 74 | 14 | 37.89844 | 92 | 1.5 | 0.399963 | 2.599609 | 148 | 7.199219 | null | null | null | null | null |
<2 mo. follow-up
| 3.002441 |
4,273 | 58.92999 | 0 |
female
| 0 | 79 | 1,307 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 37 | 128,515.375 | 85,647.1875 | null | 16.5 |
white
| 25.398438 | 51 | 0.642944 | 0.541992 | 5 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 79 | 137 | 16.898438 | 160 | 29 | 39 | 360 | 1.599854 | 0.699951 | 0.399963 | 136 | 7.459961 | null | null | null | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
4,274 | 38.74597 | 0 |
female
| 0 | 20 | 1,307 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 0 | 132,709.625 | 93,150.0625 | null | 15 |
white
| 25.5 | 37 | 0.807983 | 0.743896 | 39 | 1 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 20 | 109 | 1.699951 | 66 | 22 | 36.29688 | 290 | 1.599854 | 0.699951 | 1.899902 | 136 | 7.419922 | null | null | null | 0 | 0 | null | 0 |
4,275 | 29.62099 | 1 |
female
| 0 | 15 | 19 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
>$50k
| 89 | 53,349.375 | 34,999 | null | 34.666657 |
white
| 39.695313 | 35 | 0.17099 | 0.08699 | 1 | 0 | 0 |
yes
| 0.5 | 0.4 |
no dnr
| 15 | 75 | 2.699707 | 50 | 29 | 35.29688 | 256 | 2.699707 | 0.599976 | 0.5 | 118 | 7.449219 | null | null | null | null | 7 |
<2 mo. follow-up
| 7 |
4,276 | 64.54199 | 1 |
female
| 0 | 31 | 100 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 213,444.5 | 144,919 | null | 17.5 |
white
| 22.699219 | 28 | 0.766968 | 0.629883 | 59 | 0 | 0 |
no
| null | null |
no dnr
| 31 | 112 | 7.599609 | 124 | 40 | 38 | 233.3125 | null | null | 0.5 | 139 | 7.40918 | null | null | null | null | null | null | 2.526367 |
4,277 | 77.40698 | 1 |
male
| 1 | 7 | 7 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 12 | null | 37 | 37,871.438 | 24,670.9062 | null | 23 |
white
| 43.398438 | 102 | 0 | 0 | 14 | 1 | 0 |
metastatic
| null | null |
dnr after sadm
| 6 | 51 | 4.599609 | 104 | 26 | 34.29688 | 176 | 1.399902 | 5.799805 | 4.5 | 137 | 7.329102 | null | null | null | null | 6 |
<2 mo. follow-up
| 6 |
4,278 | 55.491 | 0 |
female
| 0 | 33 | 1,301 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 15 |
$25-$50k
| 0 | 98,300.812 | 64,919.1562 | null | 26 |
white
| 21.199219 | 30 | 0.849976 | 0.797974 | 3 | 0 | 0 |
no
| null | null |
no dnr
| 33 | 111 | 6.899414 | 110 | 40 | 38.29688 | 373.3125 | 2.399902 | null | 0.5 | 141 | 7.349609 | null | null | null | null | 0 |
SIP>=30
| 0 |
4,279 | 74.96497 | 1 |
female
| 1 | 12 | 12 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 35,012.969 | 22,773.625 | null | 38.5 |
white
| 27.398438 | 56 | 0.651978 | 0.552979 | 6 | 0 | 0 |
no
| 0.3 | 0.3 |
no dnr
| 12 | 67 | 16.398438 | 150 | 48 | 36.29688 | 223.3125 | 2.299805 | 1.099854 | 1.599854 | 135 | 7.40918 | null | null | null | null | 5 |
<2 mo. follow-up
| 5 |
4,280 | 65.41498 | 1 |
female
| 0 | 14 | 803 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 14 |
under $11k
| 0 | 14,174 | null | null | 9.333328 |
white
| 20.199219 | 29 | 0.825928 | 0.716919 | 1 | 0 | 0 |
yes
| 0.8 | 0.8 |
dnr before sadm
| 0 | 80 | 8.699219 | 80 | 25 | 37.79688 | 201.65625 | 3.899902 | 0.799927 | 2.299805 | 139 | 7.319336 | 337 | 41 | 3,800 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,281 | 44.909 | 1 |
male
| 1 | 24 | 24 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 12 | null | 26 | 55,018 | null | null | 17.333328 |
white
| 43.398438 | 59 | 0.311951 | 0.198975 | 3 | 0 | 0 |
no
| 0.75 | 0.7 |
dnr after sadm
| 24 | 46 | 10.898438 | 122 | 33 | 36.09375 | null | 2.599609 | 1 | 1.299805 | 144 | null | 94 | 20 | 4,950 | null | 0 |
<2 mo. follow-up
| 0 |
4,282 | 65.31396 | 1 |
female
| 0 | 40 | 129 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 0 | 57,653 | null | null | 23.25 |
white
| 26.398438 | 46 | 0.768921 | 0.694946 | 1 | 0 | 0 |
no
| 0.75 | 0.6 |
no dnr
| 40 | 73 | 7.399414 | 138 | 32 | 38.89844 | 400 | null | 0.699951 | 0.699951 | 138 | 7.419922 | 88 | 4 | 1,600 | null | 1 | null | 1 |
4,283 | 50.396 | 0 |
female
| 0 | 35 | 1,086 |
Coma
|
Coma
| 1 | 12 |
$25-$50k
| 44 | 90,395 | null | null | 24.75 |
white
| 26.296875 | 38 | 0.544922 | 0.475952 | 2 | 1 | 0 |
no
| 0.05 | 0.05 |
dnr after sadm
| 3 | 73 | 6.799805 | 54 | 22 | 36.69531 | null | 2.5 | 2.399902 | 0.599976 | 137 | null | 66 | 9 | 1,100 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,284 | 39.26898 | 1 |
female
| 1 | 7 | 7 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 13 |
$25-$50k
| 9 | 75,303 | 47,321.2812 | 45,979 | 29 |
white
| 36.59375 | 83 | 0.169983 | 0.085999 | 20 | 0 | 0 |
metastatic
| 0.5 | 0 |
dnr after sadm
| 2 | 73 | 5.599609 | 80 | 25 | 37.79688 | 247.59375 | 3.599609 | 0.699951 | 2.5 | 138 | 7.489258 | 104 | 53 | null | null | 1 |
<2 mo. follow-up
| 1 |
4,285 | 69.13599 | 1 |
female
| 1 | 3 | 3 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 14 |
$25-$50k
| 0 | 18,689 | null | null | 46 |
white
| 75.296875 | 87 | 0 | 0 | 1 | 1 | 0 |
no
| 0.1 | 0.5 |
no dnr
| 3 | 73 | 23.597656 | 108 | 26 | 36.19531 | 410.6875 | 3.099609 | null | 1.199951 | 141 | 7.359375 | 291 | 38 | 1,605 | null | 2 |
<2 mo. follow-up
| 2 |
4,286 | 40.34998 | 1 |
female
| 0 | 4 | 70 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 13 | null | 0 | 2,466 | null | null | 8 |
black
| 22.699219 | 36 | 0.897949 | 0.828979 | 1 | 0 | 0 |
no
| 0.4 | 0.05 |
dnr after sadm
| 1 | 110 | 5.5 | 60 | 20 | 36.09375 | 276.1875 | null | null | 1.099854 | 137 | 7.349609 | 152 | 23 | 550 | 6 | null |
adl>=4 (>=5 if sur)
| 4.527344 |
4,287 | 67.87695 | 1 |
male
| 0 | 17 | 767 |
Colon Cancer
|
Cancer
| 1 | 12 | null | 0 | 32,329 | null | null | 19.333328 |
white
| 41.398438 | 33 | 0.218994 | 0.022999 | 1 | 0 | 0 |
metastatic
| 0.93 | 0.8 |
no dnr
| 17 | 67 | null | 60 | 25 | 38.29688 | 370.3125 | 2.599609 | null | 1.599854 | 142 | 7.419922 | 278 | 24 | 1,300 | null | 1 | null | 1 |
4,288 | 76.71997 | 1 |
female
| 0 | 8 | 736 |
Lung Cancer
|
Cancer
| 2 | 18 |
$11-$25k
| 0 | 11,391 | null | null | 15.5 |
white
| 22.796875 | 14 | 0.537964 | 0.214996 | 1 | 1 | 0 |
metastatic
| 0.8 | 0.6 |
no dnr
| 8 | 77 | 21.296875 | 80 | 20 | 36.09375 | 300 | null | 1.299805 | 0.899902 | 140 | 7.429688 | 136 | 11 | null | 3 | 1 | null | 1 |
4,289 | 47.52399 | 0 |
male
| 0 | 93 | 1,082 |
Coma
|
Coma
| 0 | 14 | null | 89 | 154,483 | 100,133.438 | 94,355 | 26.75 |
white
| 18.796875 | 16 | 0.541992 | 0.472961 | 3 | 0 | 0 |
no
| 0.8 | 0.75 |
dnr after sadm
| 42 | 56 | 5.099609 | 102 | 40 | 38.29688 | 330 | 2.899902 | null | 1.099854 | 136 | 7.479492 | 108 | 16 | 5,380 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,290 | 80.68994 | 1 |
female
| 1 | 4 | 4 |
Coma
|
Coma
| 2 | 6 |
$11-$25k
| 100 | 67,555 | null | null | 40 |
white
| 21.296875 | 37 | 0.064987 | 0.035995 | 15 | 1 | 0 |
no
| 0.05 | 0.05 |
dnr after sadm
| 3 | 107 | 7.399414 | 68 | 20 | 36.39844 | null | null | null | 0.799927 | 135 | null | 93 | 12 | null | null | null |
<2 mo. follow-up
| 3.039551 |
4,291 | 46.39297 | 1 |
male
| 0 | 29 | 60 |
MOSF w/Malig
|
ARF/MOSF
| 0 | null | null | 0 | 46,628 | null | null | 20.75 |
white
| 16.699219 | 17 | 0.835938 | 0.779907 | 1 | 0 | 0 |
yes
| 0.8 | 0.5 |
no dnr
| 29 | 52 | 12.298828 | 107 | 8 | 35.59375 | 135 | null | 0.5 | 2.899902 | 142 | 7.319336 | 99 | 65 | 2,095 | null | null | null | 1.986816 |
4,292 | 68.96899 | 1 |
male
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 13 | null | 0 | 46,514 | null | null | 50 |
white
| 53.898438 | 98 | 0.022999 | 0.004999 | 31 | 0 | 0 |
no
| 0.1 | 0.1 |
no dnr
| 4 | 107 | 9.599609 | 76 | 16 | 37.09375 | null | null | 0.5 | 1.099854 | 144 | null | 63 | 17 | null | null | 2 |
<2 mo. follow-up
| 2 |
4,293 | 67.67395 | 1 |
male
| 1 | 35 | 35 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
>$50k
| 37 | 162,435 | null | null | 37.75 |
hispanic
| 30.296875 | 72 | 0.41394 | 0.293945 | 15 | 0 | 0 |
no
| 0.2 | 0.2 |
dnr after sadm
| 35 | 70 | 5.899414 | 80 | 20 | 35.59375 | 400 | null | null | 2.099609 | 143 | 7.5 | 139 | 24 | null | null | 0 |
<2 mo. follow-up
| 0 |
4,294 | 58.22897 | 1 |
male
| 0 | 6 | 195 |
Colon Cancer
|
Cancer
| 1 | 16 |
>$50k
| 0 | 10,123 | null | null | 9 |
white
| 13.699219 | 6 | 0.866943 | 0.701904 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.6 |
no dnr
| 6 | 119 | 16.398438 | 102 | 28 | 35.59375 | 113.32812 | 2.5 | 0.299988 | 0.699951 | 137 | 7.509766 | 72 | 13 | 3,265 | 1 | 1 |
no(M2 and SIP pres)
| 1 |
4,295 | 55.99698 | 1 |
male
| 0 | 78 | 183 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 325,893 | null | null | 39 |
white
| 38.695313 | 54 | 0.441956 | 0.322998 | 15 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 78 | 77 | 6.799805 | 70 | 20 | 36.09375 | null | 3.699707 | 2.099609 | 2.299805 | 138 | null | 120 | 35 | null | null | null |
Coma or Intub
| 2.189453 |
4,296 | 59.38397 | 0 |
male
| 0 | 41 | 1,078 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 8 |
under $11k
| 0 | 92,841 | 64,880.2812 | 57,448 | 22.75 |
white
| 28.898438 | 47 | 0.704956 | 0.615967 | 5 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 41 | 37 | 0.399963 | 188 | 10 | 36.09375 | 140 | 2.299805 | 1.299805 | 1 | 143 | 7.459961 | 150 | 31 | 2,235 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
4,297 | 34.853 | 0 |
female
| 0 | 29 | 1,077 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 16 |
$25-$50k
| 0 | 67,010 | null | null | 21 |
white
| 26.699219 | 24 | 0.850952 | 0.799927 | 2 | 0 | 0 |
no
| 0.7 | 0.7 |
no dnr
| 29 | 69 | 0.699951 | 77 | 32 | 39.39844 | 170 | 2.799805 | 2.099609 | 2.799805 | 134 | 7.469727 | 118 | 46 | 3,410 | null | 7 |
no(M2 and SIP pres)
| 7 |
4,298 | 68.39996 | 0 |
male
| 0 | 17 | 1,076 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 45,859 | null | null | 13.666664 |
white
| 16.597656 | 7 | 0.851929 | 0.800903 | 7 | 0 | 0 |
no
| 0.75 | 0.5 |
dnr after sadm
| 2 | 63 | 6.299805 | 110 | 6 | 39.89844 | 312.5 | null | null | 1.399902 | 132 | 7.329102 | 165 | 10 | 6,990 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,299 | 54.84198 | 0 |
male
| 0 | 10 | 1,076 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 15 |
$11-$25k
| 0 | 30,104 | 19,874.3594 | 17,731 | 15.5 |
black
| 24.796875 | 38 | 0.800903 | 0.734985 | 4 | 1 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 10 | 110 | 6.399414 | 116 | 46 | 39.19531 | 130 | null | 8.798828 | 1 | 129 | 7.439453 | 124 | 18 | 1,515 | 1 | 0 |
no(M2 and SIP pres)
| 0 |
4,300 | 51.19498 | 1 |
male
| 1 | 17 | 17 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 17 |
under $11k
| 0 | 110,430 | null | null | 36 |
white
| 33.59375 | 63 | 0.634888 | 0.532959 | 7 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 17 | 41 | 17.5 | 44 | 12 | 39 | 130 | 2.099609 | 2.599609 | 1.599854 | 145 | 7.429688 | 184 | 15 | 2,240 | null | null |
<2 mo. follow-up
| 2.17334 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.